The “Unhealthy/Pro-inflammatory” profile was positively loaded by the serum concentration of CRP, which has been positively associated with postmenopausal breast cancer in a prospective nested case-control study within the EPIC-Varese cohort study [8] and several meta-analyses [11,12,13]. This evidence concerns the gene CRP and breast carcinoma.